What is the market share of GSK?
What is the market share of GSK?
GlaxoSmithKline Plc – 4.19%
Is GSK a good share buy?
According to the Financial Times, five analysts rate GSK stock a buy; six say Glaxo’s share price has the potential to outperform the market in the next 12 months; 16 have a hold rating in place; and two say GSK shares will underperform. There are no sell ratings.
What is the capital of GSK?
PREMARKET
| Capital Structure – GlaxoSmithKline Pharmaceuticals Ltd. | ||
|---|---|---|
| From | To | Capital (Rs. Cr) |
| 2020 | 2021 | 169.4 |
| 2019 | 2020 | 169.4 |
| 2018 | 2019 | 169.4 |
Who owns GSK shares?
Unilever
On 3 December 2018, GSK announced that Unilever would acquire the Indian-listed GlaxoSmithKline Consumer Healthcare business for US$3.8 billion (£2.98 billion). Unilever will pay the majority of the deal in cash, with the remaining being paid in shares in its Indian operation, Hindustan Unilever Limited.
Which is the No 1 pharmaceutical company in the world?
Roche is the world’s largest spender in pharmaceutical research and development and the world’s number 1 in biotech with 17 biopharmaceuticals on the market. Roche is headquartered in Basel, Switzerland.
Is GSK a Buy Sell or Hold?
GlaxoSmithKline PLC holds several positive signals, but we still don’t find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
When should I sell a share?
There are generally three good reasons to sell a stock. First, buying the stock was a mistake in the first place. Second, the stock price has risen dramatically. Finally, the stock has reached a silly and unsustainable price.
Who are GSK largest shareholders?
Top 10 Owners of GlaxoSmithKline PLC
| Stockholder | Stake | Shares owned |
|---|---|---|
| Dodge & Cox | 3.51% | 88,209,189 |
| Capital Research & Management Co…. | 0.90% | 22,676,745 |
| Fisher Asset Management LLC | 0.70% | 17,547,991 |
| T. Rowe Price Associates, Inc. (I… | 0.58% | 14,668,615 |
Is GSK a UK company?
GlaxoSmithKline (GSK), formerly Glaxo Wellcome, British-based pharmaceutical company with research-and-development centres in the United States, Belgium, and China as well as the United Kingdom.
What can I do with my GSK dividend?
With the GSK Dividend Reinvestment Plan (DRIP) you can use your cash dividends to buy more shares in GSK. As an alternative to the dividend payment, your cash will be used to buy additional shares. The DRIP is a convenient, easy and cost-effective way to build your shareholding.
What is the stock price of GlaxoSmithKline?
GlaxoSmithKline’s stock was trading at $39.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GSK shares have decreased by 0.1% and is now trading at $39.84.
Who are the major holders of GSK stock?
GSK stock was acquired by a variety of institutional investors in the last quarter, including Capital International Investors, Credit Suisse AG, Acadian Asset Management LLC, Black Creek Investment Management Inc., BlackRock Inc., Equity Investment Corp, Fisher Asset Management LLC, and Mondrian Investment Partners LTD.
What is the hold rating on GlaxoSmithKline?
A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares. View analyst ratings for GlaxoSmithKline or view top-rated stocks. What stocks does MarketBeat like better than GlaxoSmithKline?